VanEck Pharmaceutical ETFVanEck Pharmaceutical ETFVanEck Pharmaceutical ETF

VanEck Pharmaceutical ETF

No trades
See on Supercharts

Key stats

Assets under management (AUM)
‪630.08 M‬USD
Fund flows (1Y)
‪202.11 M‬USD
Dividend yield (indicated)
1.64%
Discount/Premium to NAV
0.7%

About VanEck Pharmaceutical ETF

Issuer
Van Eck Associates Corp.
Brand
VanEck
Expense ratio
0.36%
Home page
Inception date
Dec 20, 2011
Index tracked
MVIS US Listed Pharmaceutical 25
Management style
Passive
PPH provides exposure to the largest, US-listed multinational pharmaceutical giants in the world. The fund holds just 25 securities, including big weights in household names. Like the underlying pharmaceutical market, PPH is top heavy and has to reweight its big holdings to accommodate RIC diversification requirements, capping a single issuer to 20%. Still, it captures the space well, even after excluding Asia entirely. Overall, PPH is a great option for investors seeking exposure to big, multinational pharma companies. The index is reviewed on a semi-annual basis.

Classification

Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Pharmaceuticals
Strategy
Vanilla
Weighting scheme
Market cap
Selection criteria
Market cap
What's in the fund
Exposure type
Stocks
Health Technology
Distribution Services
Stock breakdown by region
100%
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy